419 related articles for article (PubMed ID: 23203765)
1. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.
Marie I; Josse S; Hatron PY; Dominique S; Hachulla E; Janvresse A; Cherin P; Mouthon L; Vittecoq O; Menard JF; Jouen F
Arthritis Care Res (Hoboken); 2013 May; 65(5):800-8. PubMed ID: 23203765
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pulmonary involvement between patients expressing anti-PL-7 and anti-Jo-1 antibodies.
Tomonaga M; Sakamoto N; Ishimatsu Y; Kakugawa T; Harada T; Nakashima S; Hara A; Hara S; Horai Y; Kawakami A; Mukae H; Kohno S
Lung; 2015 Feb; 193(1):79-83. PubMed ID: 25394672
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
[TBL] [Abstract][Full Text] [Related]
7. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease.
La Corte R; Lo Mo Naco A; Locaputo A; Dolzani F; Trotta F
Autoimmunity; 2006 May; 39(3):249-53. PubMed ID: 16769659
[TBL] [Abstract][Full Text] [Related]
8. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease.
Richards TJ; Eggebeen A; Gibson K; Yousem S; Fuhrman C; Gochuico BR; Fertig N; Oddis CV; Kaminski N; Rosas IO; Ascherman DP
Arthritis Rheum; 2009 Jul; 60(7):2183-92. PubMed ID: 19565490
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.
Tillie-Leblond I; Wislez M; Valeyre D; Crestani B; Rabbat A; Israel-Biet D; Humbert M; Couderc LJ; Wallaert B; Cadranel J
Thorax; 2008 Jan; 63(1):53-9. PubMed ID: 17557770
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
Jiang M; Dong X; Zheng Y
Medicine (Baltimore); 2021 May; 100(19):e25816. PubMed ID: 34106621
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
Zheng WJ; Wei W; Tang FL
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1565-8. PubMed ID: 14642109
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
Yang H; Chen Q; Sun C; Jin Q; Zhang L; Liu Q; Peng Q; Wang G; Lu X
Respir Res; 2024 May; 25(1):222. PubMed ID: 38811943
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
15. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of interstitial pneumonia with anti-Jo-1 antibodies in the absence of myositis].
Kinebuchi S; Mizuno K; Moriyama H; Ooi H; Hasegawa T; Yoshizawa H; Suzuki E; Gejyo F
Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):739-45. PubMed ID: 14584396
[TBL] [Abstract][Full Text] [Related]
17. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options in anti-jo-1 antisynthetase syndrome with interstitial lung disease: comment on the article by Marie et al.
Cavagna L; Caporali R
Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1548. PubMed ID: 23554341
[No Abstract] [Full Text] [Related]
19. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
